|Bid||70.90 x N/A|
|Ask||72.35 x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||75.60 - 75.60|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||19.81|
|Forward Dividend & Yield||1.28 (1.69%)|
|Ex-Dividend Date||Jun 25, 2020|
|1y Target Est||N/A|
"We got off to a good start in the financial year," said Dietmar Siemssen, CEO of Gerresheimer AG. "Our high value products and solutions for biotech and pharma companies saw significant growth in the first quarter. The order books are full. We are well on our way to achieving our targets for 2021. The achievements which are now becoming visible, confirm the effectiveness of our growth strategy, which will continue to roll out systematically."
At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen (57) to the end of October 2026. Dietmar Siemssen has been CEO of Gerresheimer AG since November 2018.
NEW YORK, NY / ACCESSWIRE / October 13, 2020/ Gerresheimer AG (OTCMKTS:GRRMF) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 13, 2020 at 3:00 PM Eastern Time.